ClinicalTrials.gg
RecruitingNCT07881640Updated Oct 19, 2026

Effect of Alpha-Band Binaural Beats on Stress and Recovery in Third Molar Surgery

An interventional study of 10 Hz Alpha-Band Binaural Beats Track and Continuous Rain Sound (Placebo) in Dental Anxiety, Postoperative Pain and Impacted Tooth, sponsored by Alperen Kalyoncu. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 18 Years to 45 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-10-19.

Sponsored by Alperen Kalyoncu · Not applicable, Interventional, and Supportive care

Updated Oct 19, 2026Newly registeredGo to Updates ↓
Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
18 Years to 45 Years
Sex
All
01

Study summary

Preoperative anxiety and loud equipment noises, such as dental drills, create significant stress and autonomic fluctuations in patients undergoing oral surgery. Brainwave entrainment using alpha-band (10 Hz) binaural beats is a non-invasive audio method designed to promote relaxation and activate the parasympathetic nervous system. The purpose of this randomized controlled clinical trial is to evaluate the clinical effectiveness of a 10 Hz alpha-band binaural beat track embedded in continuous rain sound on reducing perioperative anxiety, maintaining hemodynamic stability, and improving postoperative recovery in patients undergoing impacted third molar extraction. Fifty-four healthy adult participants (ASA I) scheduled for impacted third molar surgery will be randomly assigned into three groups:Binaural Beats Group: Listening to 10 Hz alpha binaural beats embedded in a rain sound via active noise-cancelling (ANC) headphones during surgery. Placebo Group: Listening to rain sound only via ANC headphones during surgery. Active Control Group: Wearing ANC headphones with no audio broadcast (noise cancellation feature only). Preoperative dental anxiety, hemodynamic parameters (blood pressure, heart rate, oxygen saturation) at four distinct intraoperative stages, post-surgical stress levels, and 7-day postoperative pain/analgesic consumption will be measured and compared among the groups.

Read the detailed description

Dental anxiety and phobia are common psychological challenges that frequently lead to treatment avoidance, increased stress, and heightened pain perception during surgical procedures. High-frequency acoustic triggers generated by dental handpieces further exacerbate acute intraoperative stress and autonomic reactivity. While pharmacological management options exist, non-pharmacological neuromodulatory interventions provide safe and non-invasive alternatives with minimal side effects. Binaural beats occur when two slightly different auditory frequencies are presented separately to each ear, causing the brainstem's superior olivary complex to perceive a third oscillating frequency. Alpha-band frequencies (8-13 Hz) are associated with reduced state anxiety and enhanced parasympathetic tone. Integrating a 10 Hz binaural beat into continuous broadband masking noise (rain sound) aims to deliver therapeutic neuromodulation while simultaneously masking high-frequency clinical sounds. Study Protocol and Workflow:Preoperative Evaluation: Eligible participants complete the Modified Dental Anxiety Scale (MDAS) questionnaire in the waiting room prior to surgery. Randomization \& Blinding: Participants are randomized into three equal groups (n=30 per group) using sealed envelopes. Outcome assessors and statisticians are blinded to group allocation. Surgical Standardization: All surgical extractions are performed by a single experienced oral and maxillofacial surgeon following standardized surgical protocols (local anesthesia, mucoperiosteal flap elevation, bone drilling/tooth sectioning under saline irrigation, and primary suturing). Hemodynamic Monitoring: Heart rate (HR), systolic blood pressure (SBP), diastolic blood pressure (DBP), and oxygen saturation (SpO2) are recorded at four physiological stress milestones:T0: Baseline resting state in the dental chair. T1: Moment of local anesthesia administration. T2: Maximum stress period during bone drilling and tooth sectioning. T3: Recovery phase following final suture placement. Postoperative Assessment: Immediately after surgery, perceived stress and discomfort are measured using a 10-point Visual Analogue Scale (VAS). Patients are provided with a 7-day pain diary to record daily maximum pain scores (VAS 0-10) and total analgesic tablet consumption.

02

Conditions studied

  • Dental Anxiety
  • Postoperative Pain
  • Impacted Tooth
  • Binaural Beats

Keywords

  • Binaural Beats
  • Alpha Band
  • Dental Anxiety
  • Third Molar Surgery
  • Hemodynamic Stability
  • Audio Analgesia
03

In context

Pain, Postoperative

5,224 studies on the registry are indexed under Pain, Postoperative; 1,154 are open to participants now.

This study's planned enrollment of 90 is above the median of 75 across 4,457 interventional studies indexed under Pain, Postoperative.

Browse Pain, Postoperative studies →

Lead sponsor

This is the only study on the registry with Alperen Kalyoncu as lead sponsor.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
18 Years to 45 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Systemically healthy patients classified as American Society of Anesthesiologists (ASA) physical status I
  • Aged between 18 and 45 years
  • Requiring surgical extraction of at least one impacted mandibular third molar
  • Normal hearing acuity in both ears
  • Voluntary participation and signed written informed consent

Exclusion criteria

Exclusion Criteria:

  • Presence of any systemic disease (ASA II or higher)
  • History of hearing impairment, acoustic trauma, or tinnitus
  • History of neurological disorders, epilepsy, or psychiatric conditions
  • Current use of psychotropic, sedative, or analgesic medications within 48 hours prior to surgery
  • Pregnancy or lactation
  • Known allergy to local anesthetics or prescribed medications
  • Active acute pericoronitis or severe localized infection at the surgical site
05

Study design

Phase
Not applicable
Primary purpose
Supportive care
Allocation
Randomized
Intervention model
Parallel assignment
Masking
Double (Investigator, Outcomes assessor)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    Binaural Beats Group

    Participants in this group wear active noise-cancelling (ANC) Bluetooth headphones during the surgical procedure and listen to a 10 Hz alpha-band binaural beat track embedded in continuous relaxing rain sound.

    Device: 10 Hz Alpha-Band Binaural Beats Track

  • Placebo comparator
    Placebo Group

    Participants in this group wear identical active noise-cancelling (ANC) Bluetooth headphones during the surgical procedure and listen only to continuous relaxing rain sound without any embedded binaural beats.

    Device: Continuous Rain Sound (Placebo)

  • Active comparator
    Active Control Group

    Participants in this group wear identical active noise-cancelling (ANC) Bluetooth headphones during the surgical procedure with no audio broadcast, using only the active noise cancellation feature to isolate ambient clinical noises.

    Device: Active Noise Cancellation (ANC)

Interventions

  • Device10 Hz Alpha-Band Binaural Beats Track

    Participants listen to a 10 Hz alpha-band binaural beat track embedded in continuous relaxing rain sound delivered via active noise-cancelling (ANC) Bluetooth headphones during the surgical procedure.

  • DeviceContinuous Rain Sound (Placebo)

    Participants listen to continuous relaxing rain sound without embedded binaural beats delivered via active noise-cancelling (ANC) Bluetooth headphones during the surgical procedure.

  • DeviceActive Noise Cancellation (ANC)

    Participants wear active noise-cancelling (ANC) Bluetooth headphones with no audio broadcast (ANC feature active only) during the surgical procedure.

06

What researchers measure

Primary outcomes

  1. Heart Rate

    Measured in beats per minute (bpm) using a digital pulse oximeter to evaluate autonomic cardiovascular response to surgical stress.

    Time frame: Baseline (preoperative), during local anesthesia injection, during bone drilling/tooth sectioning, and at final suture placement

  2. Systolic and Diastolic Blood Pressure

    Measured in mmHg using an automatic digital blood pressure monitor.

    Time frame: Baseline (preoperative), during local anesthesia injection, during bone drilling/tooth sectioning, and at final suture placement

  3. Oxygen Saturation

    Measured as percentage (%) using a digital pulse oximeter.

    Time frame: Baseline (preoperative), during local anesthesia injection, during bone drilling/tooth sectioning, and at final suture placement

Secondary outcomes

  1. Preoperative Dental Anxiety Score

    Assessed using the Modified Dental Anxiety Scale (MDAS). Total scores range from 5 (no anxiety) to 25 (extreme dental phobia).

    Time frame: Preoperatively in the waiting room prior to surgery.

  2. Postoperative Daily Pain Intensity

    Daily maximum pain intensity recorded on a 10-point Visual Analogue Scale (VAS) ranging from 0 (no pain) to 10 (worst/unbearable pain).

    Time frame: Immediately after completion of the surgical procedure + Daily for 7 consecutive postoperative days.

  3. Postoperative Daily Analgesic Consumption

    Total number of prescribed analgesic tablets consumed per day.

    Time frame: Daily for 7 consecutive postoperative days.

07

Study locations

1 of 1 sites recruiting
08

References and documents

Study documents

  • Protocol, analysis plan and consent form · Oct 5, 2026

Documents are hosted by the registry — open the source record to download them.

Individual participant data

Plan to share: No

09

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reachedSimilar studies: half by the dot; the band is the middle halfHalf of similar studies reached it by the dot; the band is the middle half, from a quarter to three quarters

Started Sep 2026 (actual). Primary completion is estimated for Dec 2026, 2 months after the start.

Of 1,888 non-industry interventional studies with no phase under Pain, Postoperative, half reached primary completion within 11 months of starting (the median), counting those still running; a quarter within 6 and three quarters within 23. This study's planned 2 months is below that.

Counting every sponsor, half of 1,901 studies reached it within 11 months; a quarter within 6 and three quarters within 23.

How these figures are worked out, and which studies are left out of them.

Registered
Sep 21, 2026
First posted
Oct 19, 2026
StartActual
Sep 28, 2026
Primary completionEst.
Dec 15, 2026
CompletionEst.
Dec 30, 2026
Last update
Oct 19, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Oct 19, 2026
Show all 1 update
  1. Oct 19, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

10

Registry details

Key details

Study ID
NCT07881640
Lead sponsor
Alperen Kalyoncu
Responsible party
Alperen Kalyoncu (Assistant Professor, Recep Tayyip Erdogan University) — Sponsor-investigator
First posted
Oct 19, 2026
Start date
Sep 28, 2026
Primary completion
Dec 15, 2026 (estimated)
Completion
Dec 30, 2026 (estimated)
Last update
Oct 19, 2026

Study contacts

Alperen Kalyoncu
Contact
alperen.kalyoncu@erdogan.edu.tr
+905058261967

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion